English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 25, 2026

Experts call for WHO to classify ocular toxoplasmosis as a neglected tropical disease
+ Pharmaceuticals
Patient Daily | Jun 25, 2026

Blood metabolites linked to lifestyle factors may predict brain health before dementia
+ Pharmaceuticals
Patient Daily | Jun 25, 2026

FDA approves Gilead’s Trodelvy and Keytruda combo for first-line breast cancer treatment
+ Pharmaceuticals
Patient Daily | Jun 25, 2026

Researchers develop new cell culture method to study antibody regulation
+ Pharmaceuticals
Patient Daily | Jun 25, 2026

Review highlights roles of lactate and lactylation in pancreatic ductal adenocarcinoma
+ Pharmaceuticals
Patient Daily | Jun 25, 2026

FDA approves expanded use of Tryngolza for severe hypertriglyceridemia patients
+ Pharmaceuticals
Patient Daily | Jun 25, 2026

J-Valve transfemoral system shows positive one-year results for severe aortic regurgitation
+ Pharmaceuticals
Patient Daily | Jun 25, 2026

Labs report increased demand for nitrosamine, topical and microbiome testing services

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation